Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1). - Neuhann JM; Stemler J; Carcas AJ; Frías-Iniesta J; Akova M; Bethe U; Heringer S; Salmanton-García J; Tischmann L; Zarrouk M; Cüppers A; Grothe J; et al. (Vaccine, 2023)